← Scroll for more →
Merck & Co., Inc. (MRK)
Pharmaceutical Preparations
Latest Price
$149.52
TTM P/E
119.62
Normalized P/E
37.20
TTM Div Yield
2.25%
Fwd Div Yield
2.25%
Book Value
16.98
P/B Ratio
8.81
Valuation metrics
adjust assumptions →EPS: $7.28
Book value / share: $21.26
Formula: √(22.5 × EPS × BVPS)
Graham Number
$59.01
61% downside
Norm. op. income: $14.7B (median of 7yr)
Tax rate: 14%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$37.17
75% downside
Base FCF: $12.4B (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$71.12
52% downside
EPS: $7.28
Target P/E: 37×
Formula: EPS × P/E
P/E Fair Value
$269.36
+80% upside
Institutional Ownership
81.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 227.00M | $29.17B | 9.20% | +1.07M | 2026-06-30 |
| Vanguard Capital Management LLC | 161.32M | $20.73B | 6.53% | +335.6K | 2026-06-30 |
| State Street Corp | 120.41M | $15.57B | 4.88% | +1.09M | 2026-06-30 |
| Wellington Management Group LLP | 86.25M | $11.08B | 3.49% | +1.93M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 67.74M | $8.70B | 2.74% | +434.7K | 2026-06-30 |
| Geode Capital Management, LLC | 60.74M | $7.79B | 2.46% | +1.19M | 2026-06-30 |
| Sixth Street Partners Management Company, L.P. | 54.37M | $6.99B | 2.20% | -- | 2026-06-30 |
| Charles Schwab Investment Management Inc | 54.37M | $6.99B | 2.20% | +4.60M | 2026-06-30 |
| Morgan Stanley | 48.64M | $6.25B | 1.97% | +1.01M | 2026-06-30 |
| FMR LLC | 45.44M | $5.84B | 1.84% | +924.3K | 2026-06-30 |